Mohd Redzwan Sabran, Abd Mutalib Mohd Sokhini, Wang Jia-Sheng, Ahmad Zuraini, Kang Min-Su, Abdul Rahman Nurul 'Aqilah, Nikbakht Nasrabadi Elham, Jamaluddin Rosita
1Department of Nutrition and Dietetics, Faculty of Medicine and Health Sciences,Universiti Putra Malaysia,43400 Serdang,Selangor,Malaysia.
2Department of Environmental Health Science,College of Public Health,The University of Georgia,Athens,GA 30602,USA.
Br J Nutr. 2016 Jan 14;115(1):39-54. doi: 10.1017/S0007114515004109. Epub 2015 Oct 22.
Human exposure to aflatoxin is through the diet, and probiotics are able to bind aflatoxin and prevent its absorption in the small intestine. This study aimed to determine the effectiveness of a fermented milk drink containing Lactobacillus casei Shirota (LcS) (probiotic drink) to prevent aflatoxin absorption and reduce serum aflatoxin B1-lysine adduct (AFB1-lys) and urinary aflatoxin M1 concentrations. The present study was a randomised, double-blind, cross-over, placebo-controlled study with two 4-week intervention phases. In all, seventy-one subjects recruited from the screening stage were divided into two groups--the Yellow group and the Blue group. In the 1st phase, one group received probiotic drinks twice a day and the other group received placebo drinks. Blood and urine samples were collected at baseline, 2nd and 4th week of the intervention. After a 2-week wash-out period, the treatments were switched between the groups, and blood and urine samples were collected at the 6th, 8th and 10th week (2nd phase) of the intervention. No significant differences in aflatoxin biomarker concentrations were observed during the intervention. A within-group analysis was further carried out. Aflatoxin biomarker concentrations were not significantly different in the Yellow group. Nevertheless, ANOVA for repeated measurements indicated that AFB1-lys concentrations were significantly different (P=0·035) with the probiotic intervention in the Blue group. The 2nd week AFB1-lys concentrations (5·14 (SD 2·15) pg/mg albumin (ALB)) were significantly reduced (P=0·048) compared with the baseline (6·24 (SD 3·42) pg/mg ALB). Besides, the 4th week AFB1-lys concentrations were significantly lower (P<0·05) with probiotic supplementation than with the placebo. Based on these findings, a longer intervention study is warranted to investigate the effects of continuous LcS consumption to prevent dietary aflatoxin exposure.
人类通过饮食接触黄曲霉毒素,而益生菌能够结合黄曲霉毒素并防止其在小肠中吸收。本研究旨在确定含有干酪乳杆菌代田株(LcS)的发酵乳饮料(益生菌饮料)预防黄曲霉毒素吸收以及降低血清黄曲霉毒素B1-赖氨酸加合物(AFB1-lys)和尿中黄曲霉毒素M1浓度的有效性。本研究是一项随机、双盲、交叉、安慰剂对照研究,包括两个为期4周的干预阶段。总共从筛选阶段招募的71名受试者被分为两组——黄组和蓝组。在第一阶段,一组每天饮用两次益生菌饮料,另一组饮用安慰剂饮料。在干预的基线、第2周和第4周采集血液和尿液样本。经过2周的洗脱期后,两组交换治疗方案,并在干预的第6周、第8周和第10周(第二阶段)采集血液和尿液样本。在干预期间,未观察到黄曲霉毒素生物标志物浓度有显著差异。进一步进行了组内分析。黄组中黄曲霉毒素生物标志物浓度无显著差异。然而,重复测量的方差分析表明,蓝组中益生菌干预后AFB1-lys浓度有显著差异(P = 0.035)。与基线(6.24(标准差3.42)pg/mg白蛋白(ALB))相比,第2周的AFB1-lys浓度(5.14(标准差2.15)pg/mg ALB)显著降低(P = 0.048)。此外,补充益生菌后第4周的AFB1-lys浓度显著低于安慰剂组(P<0.05)。基于这些发现,有必要进行更长时间的干预研究,以调查持续食用LcS预防膳食黄曲霉毒素暴露的效果。